{
    "2018-09-28": [
        [
            {
                "time": "2018-09-04",
                "original_text": "Pfizer (PFE) Stock Moves 0.27%: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock Moves",
                        "0.27%"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-05",
                "original_text": "Final Trades: T, DIS & more",
                "features": {
                    "keywords": [
                        "Final Trades",
                        "T",
                        "DIS"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "telecommunications",
                        "entertainment"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-06",
                "original_text": "A Look at Sanofi’s Valuation Multiples in September",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Valuation Multiples",
                        "September"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "A Look at Eli Lilly’s Revenue Growth Rate",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Revenue Growth Rate"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-08",
                "original_text": "Pfizer's (PFE) Lung Cancer Drug Vizimpro Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lung Cancer Drug",
                        "Vizimpro",
                        "FDA Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-09",
                "original_text": "Women Health a Prime Concern Worldwide: 3 Stocks in Focus",
                "features": {
                    "keywords": [
                        "Women Health",
                        "Prime Concern",
                        "Worldwide",
                        "Stocks in Focus"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "PFE",
                        "LLY",
                        "Approval",
                        "Novartis",
                        "Cut Jobs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "JNK, FTXH: Big ETF Outflows",
                "features": {
                    "keywords": [
                        "JNK",
                        "FTXH",
                        "ETF Outflows"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "Stocks - Tesla Tumbles in Pre-market; Eli Lilly, BlackBerry Gain",
                "features": {
                    "keywords": [
                        "Tesla",
                        "Tumbles",
                        "Pre-market",
                        "Eli Lilly",
                        "BlackBerry",
                        "Gain"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-09-13",
                "original_text": "Pfizer's (PFE) Lung Cancer Drug Vizimpro Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lung Cancer Drug",
                        "Vizimpro",
                        "FDA Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "Comparing Pfizer Stock and Merck and Co. Stock",
                "features": {
                    "keywords": [
                        "Pfizer Stock",
                        "Merck and Co.",
                        "Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "Comparing Pfizer Stock and Johnson & Johnson Stock",
                "features": {
                    "keywords": [
                        "Pfizer Stock",
                        "Johnson & Johnson",
                        "Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-16",
                "original_text": "The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",
                "features": {
                    "keywords": [
                        "Biotech Pulse",
                        "FDA Nods",
                        "Adamis",
                        "Eli Lilly",
                        "Pfizer",
                        "Spero",
                        "Obseva",
                        "Positive Trial Results"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-17",
                "original_text": "Here’s What Verastem’s Valuation Trend Indicates",
                "features": {
                    "keywords": [
                        "Verastem",
                        "Valuation Trend"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "QIAGEN Receives FDA Approval To Expand Use Of EGFR Test In Lung Cancer",
                "features": {
                    "keywords": [
                        "QIAGEN",
                        "FDA Approval",
                        "EGFR Test",
                        "Lung Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}